Puromycin dihydrochloride, Protein biosynthesis inhibitor
Puromycin dihydrochloride, Protein biosynthesis inhibitor
Be the first to review this product! Submit a review
|
(8 Publications)
MW 544.4 Da, Purity >98%. Aminonuclease antibiotic agent. Protein biosynthesis inhibitor. Induces cell cycle arrest in G2/M phase and apoptosis. Inhibits transport of proteins into mitochondria. Inhibits translation in vivo.
查看别名
ATAD5_HUMAN, ATPase family AAA domain containing 5, ATPase family AAA domain-containing protein 5, C17orf41, Chromosome fragility-associated gene 1 protein, ELG1, Enhanced level of genomic instability 1 homolog, FRAG1, chromosome fragility associated gene 1
- Chemical Structure
Lab
Chemical Structure - Puromycin dihydrochloride, Protein biosynthesis inhibitor (AB141453)
2D chemical structure image of ab141453, Puromycin dihydrochloride, Protein biosynthesis inhibitor
产品详情
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Atad5 plays an important role in the regulation of replication fork stability and the unloading of PCNA (Proliferating Cell Nuclear Antigen) from DNA. It works as a part of a larger complex involved in DNA replication stress response. Atad5 coordinates protein biosynthesis pathways and ensures the proper completion of the DNA replication process. Oligomyosin domains in Atad5 assist in interacting with other proteins allowing it to perform its functions effectively within the cell's nuclear machinery.
Pathways
Atad5 operates in the DNA damage response and repair processes. It orchestrates the unloading of PCNA from chromatin which is important for DNA synthesis replication fork restart and repair. Atad5 associates with other proteins like RAD17 during these processes ensuring accurate DNA replication and maintaining genomic integrity. Atad5 also affects the ATR-Chk1 signaling pathway reflecting its significant role in cellular stress responses.
文献 (8)
Recent publications for all applications. Explore the full list and refine your search
Journal of Cancer 15:6434-6451 PubMed39513122
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:7712 PubMed39231947
2024
Applications
Unspecified application
Species
Unspecified reactive species
The New phytologist 241:2075-2089 PubMed38095260
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 10:896014 PubMed35874841
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 79:280 PubMed35507080
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:890974 PubMed35592418
2022
Applications
Unspecified application
Species
Unspecified reactive species
Theranostics 11:805-823 PubMed33391506
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death and differentiation 27:1086-1104 PubMed31367013
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com